Patients with insomnia had an increased risk of migraine and nonmigraine headache compared to those without insomnia.
Migraine and insomnia have a strong association—the risk for developing insomnia increases in patients with an increased migraine headache frequency, while the risk for developing migraine positively correlates with severe insomnia. According to a recent study that evaluated the impact of migraine on the clinical presentation of insomnia, patients with insomnia had an increased risk of migraine and nonmigraine headache compared with those without insomnia.
The researchers collected data from the Korean Headache-Sleep Study (KHHS)—a nationwide cross-sectional population-based survey regarding headache and sleep in Korean adults aged 19 to 69 years old. Additionally, the study classified patients as having insomnia if the participant’s Insomnia Severity Index (ISI) score was ≥10, while the clinical presentation of insomnia symptoms was determined using total and subcomponent scores of the ISI.
“Information about the impact of migraine on the prevalence and clinical presentation of insomnia in a population-based sample is currently limited. We hypothesized that migraine affects the prevalence and clinical presentation of insomnia symptoms,” the authors noted. “The purposes of the present study were to investigate 1) the prevalence of migraine and insomnia, 2) the impact of migraine on the prevalence of insomnia, and 3) the impact of migraine on the clinical presentation of insomnia in a general population-based sample.”
In total, 2695 participants were included in the study. Of these participants, 290 individuals had insomnia and 143 individuals had migraine. The migraine and nonmigraine headache proportions were observed to be higher among those with insomnia compared with those without.
Moreover, among the participants with insomnia, the total ISI scores were not significantly different among participants with migraine, nonmigraine headache, and nonheadache. The ISI scores for noticeability of sleep problems to others were significantly higher among participants with migraine and nonmigraine headache compared with those with headache history, according to the results. The researchers noted that other ISI subcomponent scores did not differ significantly between headache status groups.
“These findings suggest that the headache status does not influence the overall severity of insomnia among affected individuals. In contrast, insomnia has a significant impact on the clinical presentation of migraine,” the authors stated. “Migraineurs with insomnia experienced a higher headache intensity and impact of headache ... compared to migraineurs without insomnia.”
The authors concluded that although the results suggest that migraine and insomnia affect each other, their asymmetric casual relationship needs further investigation in additional studies.
Reference
Kim J, Cho S-J, Kim W-J, Yang KI, Yun C-H, Chu MK. Impact of migraine on the clinical presentation of insomnia: a population-based study. J Headache Pain. 2018;19:86. doi: 10.1186/s10194-018-0916-5.
Clinical Characteristics, Outcomes of Patients With Plaque Psoriasis on Tapinarof Cream
December 5th 2023Two posters presented at the 2023 Fall Clinical Dermatology Conference examined patient demographics, clinical characteristics, and outcomes in patients with plaque psoriasis treated with tapinerof cream.
Read More
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Imetelstat Offers Benefits for Patients With MDS Who Are Red Blood Cell–Transfusion Dependent
December 5th 2023The past year has offered new hope for patients with lower-risk myelodysplastic syndromes. Besides imetelstat, which has an FDA deadline for action of June 2024, the agency approved luspatercept, which has a different mechanism of action.
Read More